Quiz 1 Material Flashcards
(82 cards)
A branch of pharmaceutics that study the fate of drugs after administration to a living organism.
Pharmacokinetics
The study of drug concentration and it’s effect to the body.
Pharmacodynamics
Study of the impact of physicochemical properties of the drug and drug product on drug delivery and absorption under normal or pathological condition.
Bio-pharmaceutics
The influence of genetic variation on a drugs efficacy and toxicity
Pharmacogenomics
The technologies involving development of dosage forms
Pharmaceutical Technology
Pharmaceutics deals with all of the following except?
A. Preparation of dosage forms
B. Formulating a pure drug to dosage forms
C. Studying the physico-chemical properties of pure drug substance
D. Identifying the mechanism of action of a drug
E. Study the rate and extent of drug absorption
D. Identifying the mechanism of action of a drug
A substance used in the diagnoses, mitigation, treatment, cure, or prevention of disease in humans or other animals.
Drug
A drug that must change to an active compound after ingestion. Such conversion occurs through enzymatic and biochemical cleavage.
Pro-drug
In non-clinical development are humans involved or not?
No, non-human status
In clinical development are studies performed in humans?
Yes
A protein, enzyme, receptor, signaling, or other molecules that is/are responsible for development of a disease.
Target
A test protein, peptide, or compound that appears to act on targets.
Hit
Of the numerous hits or variants, the protein, peptide, or organic compound that show the highest degree of activity against the disease.
Lead
A protein, peptide, or organic compound that has most or all of the properties of a desired therapeutic agent.
Candidate
New Drug application, filed for initial testing of each new drug in humans.
Investigational New Drug Application
A marketed therapeutic agent
Product
First studies in humans, usually healthy humans, after obtaining IND. Single dose followed by short-term multiple dose studies - follow up for days to weeks.
Clinical Development Phase I
Determine effectiveness in conditions or diseases of interest.
Clinical Development Phase II
Confirm effectiveness in larger studies
Clinical Development Phase III
Post-approval studies
Clinical Development Phase IV
It takes about ___ years to develop a FDA approved brand name drug.
15
What kind of drug does not require preclinical development or the drug discovery process? What does this kind of drug require?
Generic Drugs
Bioequivalence study
Preclinical studies are performed in _________.
Animals
Clinical studies are performed in _______ at _______ different phases
Humans
Four